iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company advancing innovative pharmacologic therapies for refractive eye diseases, today announced key executive promotions designed to strengthen operational leadership and advance its scientific vision. Effective immediately, Michael Burr, M.B.A., M.S., has been promoted to Chief Operating Officer (COO), and Sarah Molokhia, R.Ph., Ph.D., has been promoted to Chief Scientific Officer (CSO).